Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2015-11-09 | New | $600,000 | $600,000 | Equity Only | 06b | SEC link |
| 2015-08-24 | Amended | $0 | $0 | Equity Only | 06b | SEC link |
| 2015-08-20 | New | Yet to Sell | $0 | Other | 06b | SEC link |
| 2015-08-20 | New | Yet to Sell | $0 | Other | 06b | SEC link |
| 2014-01-24 | Amended | $6,642,878 | $4,581,313 | Equity Only | 06b | SEC link |
| 2013-03-22 | New | $2,061,565 | $2,061,565 | Equity Only | 06 | SEC link |
| 2012-09-04 | New | $0 | $0 | Equity Only | 06 | SEC link |
| 2011-06-03 | Amended | $7,600,000 | $4,850,000 | Equity Only | 06 | SEC link |
| 2010-10-14 | New | $0 | $0 | Equity Only | 06 | SEC link |
| 2010-07-02 | New | $0 | $0 | Equity Only | 06 | SEC link |
| 2010-03-11 | New | $2,750,000 | $2,750,000 | Equity Only | 06 | SEC link |
| 2010-02-19 | Amended | $4,008,472 | $0 | Equity Only | 06 | SEC link |
| 2008-12-23 | Paper Filing | Unknown | $0 | Other | Not Available |
| Name | Role |
|---|---|
| Gregory H. Barnhill | Director |
| Tony Caplin | Director |
| Alan Cohen | Director |
| Hakan Edstrom | Director |
| Dan Fitzgerald | Director |
| Daniel Fitzgerald | Director |
| Michael Hagerman | Director |
| Anders Halldin | Director |
| Michael G. Hanna, Jr. | Director |
| David Hatt | Director |
| Ronald Kaiser | Director |
| Daniel Kane | Director |
| Michael Kranda | Director, Executive |
| John Nicolis | Director |
| Andrew L. Tussing | Director, Executive |